Enanta Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CCCC
C4 Therapeutics, Inc. |
$3.79 | $320.64 M | -1.97 | 145 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$12.03 | $1.29 B | -7.16 | 85 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$51.87 | $3.53 B | -11.86 | 290 | $4.01 M |
DSGN
Design Therapeutics, Inc. |
$6.25 | $217.51 M | -3.7 | 54 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$28.76 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.06 | $243.38 M | -1.59 | 133 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.55 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.54 | $84.45 M | -1.11 | 14 | $9.16 M |
INBX
Inhibrx Biosciences, Inc. |
$14.98 | $241.02 M | -1.44 | 166 | $1.80 M |
IPSC
Century Therapeutics, Inc. |
$1.04 | $244.54 M | -1.32 | 152 | $2.24 M |
KRON
Kronos Bio, Inc. |
$0.94 | $44.62 M | -0.37 | 58 | $6.29 M |
LYEL
Lyell Immunopharma, Inc. |
$0.64 | $619.50 M | -2.7 | 224 | $130,000 |
MLYS
Mineralys Therapeutics, Inc. |
$12.84 | $652.38 M | -6.03 | 28 | $0 |
MRUS
Merus N.V. |
$42.06 | $3.50 B | -19.38 | 172 | $43.95 M |
RVMD
Revolution Medicines, Inc. |
$44.21 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$11.05 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |